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A concise review of the ultrastructural features and 
physiological properties of eosinophils is presented with 
the aim of delineating those properties of eosinophils 
that set them apart from other granulocytes. It has be-
come clear that eosinophils are subject to chemotaxis by 
attractants that do not affect other cells (e.g., histamine, 
ECF-A, ESP) and that they contain antiflogistic agents 
(arysulfatase lIB, peroxidase) that neutralize specific 
substances known to elicit the inflammatory response. 
The mechanisms underlying eosinophilia in a variety of 
cutaneous disorders are analyzed in the light of this 
information. 
Although the eosinophil is not a common inhabitant of nor-
mal skin, it is not unusual for patients with cutaneous disease 
to develop blood eosinophilia or to have inflammatory infU-
trates in which this cell predominates. Consequently, derma-
tologists have been interested in eosinophils ever since these 
cells were described in 1879. Furthermore, dermatologists were 
among the first physicians to recognize that eosinophilia tends 
to accompany diseases of an allergic, neoplastic, or parasitic 
nature [for review see references I, 2]. However, since it was 
difficult to isolate eosinophils in large numbers, the functions 
and biochemistry of the cells remained unknown until the past 
decade. Even today, when it has been established that eosino- . 
phils perform functions similar to those of neutrophils, it is not 
generally known that eosinophils have some properties that 
may set them apart from other granulocytes. The most recent 
experimental data in this area have not yet been correlated 
with the histopathology of cutaneous disease. Therefore, it 
seems timely to review our present knowledge and the specific 
areas in which information is still incomplete. It may then be 
possible to formulate working hypotheses that would be useful 
in studies on eosinophilia in a variety of dermatological disor-
ders. 
EOSINOPHIL STRUCTURE AND GENERAL 
FUNCTIONS 
The appearance of eosinophils on a blood smear or in tissue 
sections is well known. They contain a bilobed nucleus, large 
acidophilic refractile granules, and a characteristic ultrastruc-
ture. (The reader is referred to previous reviews for a more 
complete description [2-4].) The granules in human eosinophils 
are membrane-bound structures that consist of 2 components, 
a central angular-shaped core often referred to as the crystalloid 
and the surrounding matrix (Fig 1-4). Depending on the fixation 
and embedding procedures used, the electron density of the 
core and matrix may vary in relation to each other [5]. Even 
more confounding is the observation that a reversal of electron 
density between matrix and core can sometimes be seen in 
adjacent granules within the same cell (Fig 2). The reasons for 
this phenomenon have not been fully explained. It is possible 
that the electron density of the matrix relative to the core of 
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the 'granule reflects the type or concentration of enzymes con-
tained in them. Or, perhaps the permeability chaI"acteristics of 
the membrane differ from one granule to another and this 
variety in turn permits variable penetration of the embedding 
media or extraction of the granule contents (Fig 4). Crystalli-
zation of the core (Fig 3) appears to take place only after the 
myelocytic stage of differentiation, and eosinophils of some 
species, e.g., the horse, do not have a central crystalloid even in 
mature cells. Thus, the physiological significance of the com-
partmentalization of substances within eosinophil granules is 
not understood. The core structure of human eosinophil gran-
ules is poorly soluble in physiologic media and it is not easily 
destroyed by osmotic, enzymatic, or mechanical means. In 
tissues in which massive destruction of eosinophils takes place, 
the cores of eosinophil granules may conglomerate and give rise 
to the so-called Charcot-Leyden crystals [6,7]. This raises the 
question of whether the inertness of these structures could be 
responsible for the foreign-body type of granuloma reaction 
seen in chronic inflammatory lesions dominated by large num-
bers of eosinophils. Concerning the biochemical nature of the 
granules, a major constituent is an arginine-rich cationic protein 
[8-10] that differs from the one responsible for the Charcot-
Leyden crystals [11]. It has also been well established that 
eosinophil granules possess the same lysosomal enzymes as 
neutrophils, but they contain a larger amount of peroxidase and 
10 times more arylsulfatase IlB than other leukocytes [12]. 
Bec'ause arylsulfatase IIB inactivates the slow reacting sub-
stance of anaphylaxis (SRS-A), it may equip the cells for a 
unique role in the immediate hypersensitivity reaction [13]. 
However, it has not yet been clarified whether degranulation of 
eosinophils is necessary for SRS-A to be inhibited or whether 
arylsulfatase may be secreted by the cell without morphological 
evidence of granule loss. 
During phagocytosis, eosinophil degranulation, which resem-
bles that of neutrophils, involves membrane fusion and dis-
charge of granule content into the phagosome [14]. The cyto-
plasm has more vesicles, ribosomes, profIles of rough endoplas-
mic reticulum, and mitochondria than that of neutrophils. 
These findings are in accord with evidence that eosinophils are 
metabolically more active than neutrophils [15,16] and that 
they have a longer life span [17]. An often ignored cytoplasmic 
structure of eosinophils is a profile of endoplasmic reticulum, 
which may assume cuplike, ring-, or dumb-bell-shaped confor-
mations (Fig 5). These structures have been called "microgI'an-
ules" and have been found in eosinophils of about 20 different 
species of mammals [18,19]. The biochemical makeup and 
function of microgranules have not yet been elucidated, but 
there appear to be increased numbers of these structures in 
some patients with eosinophilia. The nucleus of eosinophils 
resembles that of neutrophils: the heterochromatin has a pe-
ripheral distribution and the nucleolus is small or absent. In 
about 80% of normal blood eosinophils, the nucleus is bilobed. 
Hypersegmentation occurs with vitamin BI2 and/ or folate de-
ficiency, severe inanition, and following treatment with antifo-
lates. Under such circumstances, the eosinophil nuclei are hy-
persegmented and the cells could be mistaken for neutrophils 
when poorly stained. 
Properties Specific to Eosinophils 
Now that in vitro techniques are more refined it has been 
possible to discover biological functions of eosinophils that 
differ from those of other gI·anulocytes. The longstanding con-
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FIG 1. Electron micrograph of human peripheral blood eosinophil. 
Note that the granules have an electron-dense "core" and a less-
electron-dense "matrix." Numerous vesicles and profiles of smooth and 
troversy concerning the question of whether 01' not eosinophils 
are specifically attracted by histamine has been resolved. Al-
though many reports claimed that eosinophils accumulate in 
tissues in which mast cells have degranulated and that local 
eosinophilia follows intracutaneous injections of histamine 
[20], other reports claimed the contrary [21-23]. These discrep-
ancies resulted from the limited range of concentration over 
which histamine is effective. With the Boyden method of as-
sessing chemotaxis, it has been established definitively that 
eosinophils are attracted by histamine and that neutl'Ophils are 
not [24]. As is true for other chemotactic attractants that 
deactivate the cells they attract [25], a large concentration of 
histamine immobilizes eosinophils, a fact that may account for 
the retention of eosinophils in selected areas of massive hista-
mine release, e.g., in the lesions of wticaria pigmentosa, where 
mast cell degranulation occurs. Another mast cell product be-
lieved to be specifically responsible for the attraction of eosin-
ophils is the eosinophil chemotactic factor of anaphylaxis (ECF-
A), which is distinct from histamine in size and charge and 
which has been synthesized in vitro [26,27]. In addition to the 
eosinophilotactic substances released by degl'anulating mast 
cells or basophils, a factor called eosinophil-stimulating pro-
moter [28] is elaborated by antigenically and even nonspecifi-
cally stimulated lymphocytes. This substance was first isolated 
from lymphoid cells obtained from mice infected with Schisto· 
soma mansoni [29,30]. This material, like histamine, has been 
reported to attract eosinophils without any effect on other 
inflammatory cells. Experiments conducted in rodents showed 
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rough endoplasmic reticulum (ER) are evident. G, Golgi zone. Arrow 
indicates "microgranules" (x 15,000). 
that eosinophils are attracted preferentially by antigen-anti-
body complexes containing homocytotrophic antibody. When 
injected into the skin of guinea pigs, immune complexes con-
taining IgG 1 are more effective in attracting eosinophils than 
complexes containing IgG2 [31]. In man, complexes containing 
IgE are thought to playa similar role. It is not clear, however, 
whether eosinophils are attracted by the immune complexes 
themselves 01' whether the cells 8..l·e drawn to such sites second-
arily after degranulation of mast cells by the immune com-
plexes. In any case, it is conceivable that the isolation and full 
characterization of these eosinophilotactic substances may be-
come of practical importance when attraction of eosinophils to 
specific tissue sites seems desirable. This possibility raises the 
immediate question of whether 01' not transient local tissue 
eosinophilia is a beneficial event. The answer to this question 
should probably be affirmative. Eosinophils contain at least 3 
antiflogistic agents: (i) arylsulfatase IIB, which abrogates the 
effects of SRS-A; (ii) histamine oxidase, which destroys hista-
mine; and (iii) eosinophil derived inhibitor, a substance liber-
ated from eosinophils by sonication and purported to block the 
release of histamine from mast cells [32]. Recently it has been 
demonstrated that eosinophils function as effector cells in par-
asite destruction [33,34]' Antibody-coated Schistosoma larvae 
are damaged by eosinophil-rich cell preparations, whereas neu-
trophil or mononuclear cells devoid of eosinophils appear to be 
ineffective. In addition, it has been reported that anti-eosinophil 
serum administered to mice immune to Schistosoma larvae 
abrogates their immunity [35]. Although these results have not 
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F IG 2. Variable electron density of the core and matrix in adjacent 
granules of the same cell. Arrow indicates "microgranule" (x 50,000). 
FIG 3. High magnification of a granule core illustrates 40-A period-
FIG 4. Peripheral blood eosinophils from a patient with lymphoma 
cutis and severe blood eosinophilia. Note oversized granu les in both 
cells and reversal of electron density between core and matrix in the 
been confirmed by other investigators, they are compatible 
with independent observations that the skin of immune mice 
challenged with cercaria has a lO-fold increase in eosinophils in 
comparison with analogous skin sites of normal mice [36]. T hus, 
even though it is necessary to emphasize t hat the available 
information is still fragmentary, there are now suffic ient data 
to support the belief that the function of eosinophils is compa-
rable to those of oth er phagocytic cells. In addition, eosinophils 
may also play a unique role in some special types of inflam-
matory reactions. 
MECHANISM OF EOSINOPHILIA IN 
DERMATOLOGICAL DISORDERS 
Any attempt to understand the mechanisms responsible for 
eosinophilia in a particular disease should probably begin with 
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icity of its crysta lloid structure. A rrow indicates membrane surrounding 
granule. M, matrix (x 250,000). 
cell on the right. Amorphous material surrounding the cell on the right 
suggests extracted or released substance (see text) (x 6,500). 
a determination of whether (i) t here is only local tissue eosin-
ophilia, (ii) there is an elevated blood eosinophil count in th e 
absence of a local infIltrate, or (iii) if both condi t ions are 
present. In healthy human beings, eosinophils, like other gran-
ulocytes are believed to arise in the bone marrow. Therefore, 
the stimulus for accelerated eosinophil proliferation must act 
on a precursor in the bone marrow that mayor may not be 
recognizable as an eosinophil. What is the natw-e of this stim-
ulus? A series of experiments carried out primarily in Beeson's 
laboratory suggest that thymus-derived (T) lymphocytes may 
release a factor that plays a major role in the inductive phase 
of eosinophilia [37- 39]. For instance, in rats an antiserum 
prepared against T lymphocytes impeded the normal 'stimulus 
for eosinophilia and in neonatally thymectomized animals, the 
eosinophil count apparently could not rise above normal levels. 
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Although the mechanism whereby eosinophilia is induced h as 
not been fully established, it is likely that the effect is mediated 
by a humoral factor elaborated by stimulated lymphocytes 
[38]. On the assumption that these results can be corroborated, 
one might postulate that the lymphocytes that infiltrate skin 
lesions whether these be allergic, inflammatory, or neoplastic 
could also secrete such an "eosinophilia- inducing factor." In 
practice, peripheral blood eosinophilia may be encountered in 
dermatological conditions when skin biopsy specimens are de-
FIe 5. D etail of eosinophil cytoplasm. Specimen was obtained from 
the same patient whose cells lHe illustrated in Fig 4. The a,."ows 
indicate the profLles of endoplasmic reticulum that have been called 
FIe 6. a, Round cell infLl trate in skin specimen from a patient wi th 
dermatitis medicamentosa (x 165). (Section of biopsy specil11en re-
ceived through the cOUl"tesy of the Department of D ermatology at New 
York University Medical Center). b, Detail of round cell infiltrate 
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void of eosinophils. This situation is seen in some patients with 
dermatitis medicamentosa. The biopsy specimen illustrated in 
Fig 6 was obtained from a patient in whom a severe macular 
exanthem and generalized exfoliation developed after diphenyl 
hydantoin therapy. T he peripheral blood eosinophils consti-
tuted 40% of the leukocyte count and the absolute eosinophil 
level was 4,800 per cubic mill imeter (normal> 400). No eosin-
ophils were present in the skin specimen, which showed an 
infiltrate consisting predominant ly of lymphocytes mixed with 
"microgranules" (see text) and that seem to be more numerous in the 
eosinophils of some patients with eosinophilic leukocytosis (x 38,(00). 
illustrated in Fig 6A shown at higher magnification. Sma ll lymphocyte 
predominate. Some atypical mononuclear cells and histiocytes ru'e 
scattered randomly thl"oughout the infiltrate. T he complete absence of 
eosinophils is noteworthy (x 720). 
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som e neu trophils a nd histiocytes. S ince stimulated or tra ns-
formed lymphocytes h ave been incriminated in the d evelop-
ment of blood eosinophilia, it would be of interest to ident ify 
t he subpopulation of lymphocytes present in such lesio ns. 
An en tirely differen t expla nation applies to dermal lesions 
infiltrated by eosinophils in the absence of blood eosinophilia. 
In such cases, eosinophil proliferation in the bone m arrow need 
not be accelerated , and local t issue eosinophilia could be th e 
result of chem otaxis or specific eosinophil trapping. Examples 
of such lesions are the so-called persistent insect bites [40], the 
acu te reaction seen in urticaria pigm entosa, a nd th e infla m -
matory infiltrate occasionally seen surrounding parasite larvae 
[41,42]. In the fu ture, it may become possible to iden tify the 
specific chem otactic factor that is opera tive at a particular s ite. 
F urth ermore, it seems plausible that continued tra pping a nd 
subsequen t disruption of eosinophils at such a site could h ave 
th e injurious consequences usually concomitant with chronic 
inflammation in general and th e deposition of Charcot-Leyden 
crystals in particular (vide infra). It is conceivable th at wi th 
this type of local process, when chronic enough , lesions of such 
q uestiona ble nosologic en t ities as "eosinophilic gra nuloma" of 
th e skin [for review, see reference 43] could develop . The 
sequence of events t hat even tually r esults in the varied histo-
pathological a ppearance of eosinophilic granulom a would be 
difficult to dissect. On th e oth er hand, wh en eosinophils a bound 
in the skin as well as in circulating blood (as happens in 
pemphigus or herpes gestationes), t h e mech a nisms underlying 
eosinophilia m ay not be quite so complex. In such circumstances 
th e stimulus for eosinophilia persists and this fact implies th at 
the activation of lymphocytes purported to ela borate th e stim-
ulus also remains. Since th e sojourn of eosinophils in th e 
circulation lasts only a few h ours, t issue a nd lymph eosinophilia 
may be nonspecific consequences whenever the blood eosino-
phil coun t is persistent ly high. 
Somewhat more puzzling ar e diseases in which eosinophilia 
is not a consisten t finding, e.g., atopic derm atit is, de rmatit is 
herpetifo rmis [44], chronic fo rms of urticaria, a nd mycosis 
fungo ides. In som e patients with atopic derm atit is, th e eosino-
phil count appears to parallel t he serum level of IgE ; in oth er 
subjects this relationship does not seem to exis t [45]. Pat ien ts 
with lymphom a cutis m ay h a ve persisten t or tra nsien t eosino-
philia or their eosinophil count m ay never rise above the normal 
range. It m ay not be amiss to invoke genetic predisposit ion in 
the first instance and the intermittent release of stimulat ing 
factors by neoplastic lymphocytes in the second . 
This r eview does not discuss all aspects of eosinophil physi-
ology a nd pathology. I have t ried to emphasize primarily those 
p roperties of the cells t ha t seem relevant to dermatological 
diseases. H owever, it should be obvious th at th e p rocesses 
discussed are not limited to the skin and tha t similar analyses 
of the mecha nisms underlying eosinophilia are a pplicable to 
other t issues. T he cells play a n importa nt role in init iating, 
perpetua ting, and often a m eliorating the inflammatory r e-
sponses in ma ny types of tissue. If th e rate of ou r progress in 
understanding these phenomena con t inues as it has over th e 
past decade, it m ay soon become possible to ma nipulate the 
proliferation a nd migration of eosinophils to benefi t t he afflicted 
patient . 
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Hair Transplant Symposium 
The second annual H air Transplant Symposium sponsored by the American Society for Dermatologic 
Surgery, Inc., will be held at the Ritz Carlton Hotel and Northwestern University Medical School, 
Chicago, Illinois-Thursday, September 21-Sunday, September 24, 1978. 
The course will cover hair transplant technique, demonstrations, scalp implants, scalp reductions, strips 
and flaps. The course is designed for both the beginning and advanced hair transplant surgeons. 
For further information contact: J. B. Pinski, M.D., 55 East Washington, Chicago, Illinois 60602. 
